Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by steadfaston May 04, 2021 1:25pm
98 Views
Post# 33124317

RE:Let's call this a "not Red" perspective

RE:Let's call this a "not Red" perspectiveAnother Excellent Post, Donkeyfeathers:
Your sentence "there has been nothing othan than value destruction since January"
is 100% true.  January 2021 SVA starts to participate in TheMarket Melt Up and is
rewarded by Dr Witkowski on Fri Jan 15th with World Class Data, the excitement
continues at open Mon morning reaching a high of $2.87.  SVA has been given a golden
opportunity to participate in The Stock Market Euphoria.  We have no idea how high it
could go as their is interference.  The Board of Director's have another plan.  In the most
UNTIMELY MANNER POSSIBLE, they chose to do the bot deal and with a firm whose
investors shorted the hell out of the stock.  The Board of Directors have to take
responsibility for their poor and untimely judgement.

There was no need for this deal at this point in time.  SVA was in the process of
receiving $3.8M from exercise of wts.  It was time to sit back and watch SVA participate
in the eurphoria, see how high it could go. Then, SVA could  invite 3 firms to give a quote for BOT deal, including National Bank whose # of shareholders likely represent the largest holding
in SVA.  They would have gladly participated at a price higher than $1.20 and have their
Analyst write a report.   Wonder if Medtronics would have shown any interest if they
got invited?

The present members of the BoD have a tiny bit of skin in the game.  We need
Director's who are passionate about SVA and are major shareholders who will make the
best possible decisions for the shareholders.   

In fairness I am pleased this new nominee has contacts with Osuka, Sanofi and
Astra Zeneca. Let's see if he invests any money in SVA.
<< Previous
Bullboard Posts
Next >>